Cargando…
Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases
A magnetic beads (MB)-involved amperometric immunosensor for the determination of ST2, a member of the IL1 receptor family, is reported in this work. The method utilizes a sandwich immunoassay and disposable screen-printed carbon electrodes (SPCEs). Magnetic immunoconjugates built on the surface of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234531/ https://www.ncbi.nlm.nih.gov/pubmed/34205541 http://dx.doi.org/10.3390/bios11060202 |
_version_ | 1783714105363791872 |
---|---|
author | Torrente-Rodríguez, Rebeca M. Martín, Cristina Muñoz-San Gamella, Maria Pedrero, María Martínez-Bosch, Neus Navarro, Pilar García de Frutos, Pablo Pingarrón, José M. Campuzano, Susana |
author_facet | Torrente-Rodríguez, Rebeca M. Martín, Cristina Muñoz-San Gamella, Maria Pedrero, María Martínez-Bosch, Neus Navarro, Pilar García de Frutos, Pablo Pingarrón, José M. Campuzano, Susana |
author_sort | Torrente-Rodríguez, Rebeca M. |
collection | PubMed |
description | A magnetic beads (MB)-involved amperometric immunosensor for the determination of ST2, a member of the IL1 receptor family, is reported in this work. The method utilizes a sandwich immunoassay and disposable screen-printed carbon electrodes (SPCEs). Magnetic immunoconjugates built on the surface of carboxylic acid-microsized magnetic particles (HOOC-MBs) were used to selectively capture ST2. A biotinylated secondary antibody further conjugated with a streptavidin peroxidase conjugate (Strep-HRP) was used to accomplish the sandwiching of the target protein. The immune platform exhibits great selectivity and a low limit of detection (39.6 pg mL(−1)) for ST2, allowing the determination of soluble ST2 (sST2) in plasma samples from healthy individuals and patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) in only 45 min once the immunoconjugates have been prepared. The good correlation of the obtained results with those provided by an ELISA kit performed using the same immunoreagents demonstrates the potential of the developed strategy for early diagnosis and/or prognosis of the fatal PDAC disease. |
format | Online Article Text |
id | pubmed-8234531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82345312021-06-27 Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases Torrente-Rodríguez, Rebeca M. Martín, Cristina Muñoz-San Gamella, Maria Pedrero, María Martínez-Bosch, Neus Navarro, Pilar García de Frutos, Pablo Pingarrón, José M. Campuzano, Susana Biosensors (Basel) Article A magnetic beads (MB)-involved amperometric immunosensor for the determination of ST2, a member of the IL1 receptor family, is reported in this work. The method utilizes a sandwich immunoassay and disposable screen-printed carbon electrodes (SPCEs). Magnetic immunoconjugates built on the surface of carboxylic acid-microsized magnetic particles (HOOC-MBs) were used to selectively capture ST2. A biotinylated secondary antibody further conjugated with a streptavidin peroxidase conjugate (Strep-HRP) was used to accomplish the sandwiching of the target protein. The immune platform exhibits great selectivity and a low limit of detection (39.6 pg mL(−1)) for ST2, allowing the determination of soluble ST2 (sST2) in plasma samples from healthy individuals and patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) in only 45 min once the immunoconjugates have been prepared. The good correlation of the obtained results with those provided by an ELISA kit performed using the same immunoreagents demonstrates the potential of the developed strategy for early diagnosis and/or prognosis of the fatal PDAC disease. MDPI 2021-06-21 /pmc/articles/PMC8234531/ /pubmed/34205541 http://dx.doi.org/10.3390/bios11060202 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Torrente-Rodríguez, Rebeca M. Martín, Cristina Muñoz-San Gamella, Maria Pedrero, María Martínez-Bosch, Neus Navarro, Pilar García de Frutos, Pablo Pingarrón, José M. Campuzano, Susana Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases |
title | Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases |
title_full | Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases |
title_fullStr | Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases |
title_full_unstemmed | Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases |
title_short | Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases |
title_sort | electrochemical immunosensing of st2: a checkpoint target in cancer diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234531/ https://www.ncbi.nlm.nih.gov/pubmed/34205541 http://dx.doi.org/10.3390/bios11060202 |
work_keys_str_mv | AT torrenterodriguezrebecam electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases AT martincristinamunozsan electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases AT gamellamaria electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases AT pedreromaria electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases AT martinezboschneus electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases AT navarropilar electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases AT garciadefrutospablo electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases AT pingarronjosem electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases AT campuzanosusana electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases |